AcquisitionOther
Prometheus Biosciences, Inc. acquired Prometheus
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Prometheus Biosciences, Inc. -> Prometheus · $200.00
The agreement with Prometheus will accelerate our growing presence in immunology where there remains substantial unmet patient need.
Open source record (SEC) ↗